Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial -- Banikazemi et al. 146 (2): 77 -- Annals of Internal Medicine

Established in 1927 by the American College of Physicians

Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Patient Information

Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online

Return to article

Please click here to check whether you must obtain permission to reproduce this image.

Appendix Table. Adverse Events That Occurred without Regard to Causality in at Least 10% of Patients in the Agalsidase-Beta Group ${webonly}$

Return to article

Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online